We are very proud and excited to announce a new publication from Dr. José Padrón and lead author Adrián Puerta showing the benefits of using Nanolive’s label-free data analysis in Phenotypic Drug Discovery (PPD) programs. Dr. Padrón is a Professor at the Universidad...
David Agorku was the lucky winner of a competition that we ran last year offering pharma and biotech companies the chance to win the use of a CX-A for 6 months. David’s goal is to understand how T cells and fibroblast cells interact, so we provided him with a CX-A...
Introduction Dose-response curves provide important pharmacodynamic properties (efficacy, potency, toxicity, and lethality) for evaluating the performance of candidate drugs in the discovery pipeline. Half maximal effective concentration (EC50) values are a standard...
In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine. Specifically, Dr. Gibbin-Lameira will show that: Dose-dependent experiments can be...
In this webinar, Dr. Emma Gibbin-Lameira, Communications Specialist at Nanolive reveals how Nanolive imaging can be used to conduct real-time, automated cytotoxicity assays, without the contribution of photo and cytotoxic methodological artefacts. Specifically, she...
